In this study, in a well-characterized cohort of women with MO who were at different NAFLD histological stages, an increase in hepatic STING mRNA and protein expression was found, especially in the steatosis stage. The gene discussed is STING1; the disease is metabolic dysfunction-associated steatotic liver disease.